Drug Discovery at the Institute is made up of many scientists working together as a team to design, test and develop molecules that will eventually become drugs for psychiatric diseases.
Drug discovery & development: translational medicine
From compound design and creation by medicinal chemistry to testing candidates for therapeutic effect in assay development and pharmacokinetics, drug discovery is a true meld of chemistry and biology. In this arena, we have both disciplines working together towards a common goal: translational medicine.
Read more about our research in medicinal chemistry, in vivo pharmacology and assay development below.
Working to improve current therapies and develop new treatments for patients with schizophrenia and related brain disorders.
LIBD Speaker Series: Michael Gandal, M.D., Ph.D.
“Human brain functional genomic characterization of the molecular mechanisms underlying genetic risk for schizophrenia” Michael Gandal, M.D., Ph.D. Assistant Professor, Psychiatry and Biobehavioral Sciences The Gandal Lab UCLA Semel Institute for Neuroscience and Human Behavior When: November 10, 2020 2:00pm-3:00pm